Say Hello!
Don’t be shy.

   

News

Phenotypeca is pleased to report that it has purchased a substantial amount of laboratory equipment from Nottingham biotechnology company Albumedix, a recognised global leader in recombinant human albumin (rHA), specialising in the enablement of advanced therapies. This allows Phenotypeca to equip its next-generation yeast technology laboratory...

Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, is pleased to announce the successful completion of its oversubscribed Placing. The Placing was enlarged to accommodate additional investor interest from both new and existing investors.   The Placing has raised gross proceeds of £9.0 million (before commission and expenses)...

RenaSci was founded in 2001 by Dr Sharon Cheetham, Dr Rob Jones and Professor David Heal, providing an integrated blend of in vivo pharmacology consultancy and experimental services, helping clients from all sectors of the pharmaceutical and biotech industry to maximise their research productivity and streamline drug...

Image: Professors Alessio Ciulli and Sir Mike Ferguson Drugs development firm Amphista Therapeutics has unveiled a £38 million investment that will enhance its work to develop treatments for a range of diseases. The company is a spinout from Professor Alessio Ciulli’s labs at the University of Dundee’s School...